FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage...

East Hanover, October 29, 2024 – Novartis announced today that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug...

Today, the Media Rating Council (MRC) approved the integration of first-party live-streaming data into Nielsen's accredited National Television...

Warning: Louisville Patients Expose Shocking Side Effects Of Trendy Weight Loss DrugsMy holistic ND: A CEO from Novo once told a bunch of medical...

SouthCoast Wind 1 has received approval from the US state of Massachusetts for onshore transmission facilities in Somerset.

Andrew Forrest's Squadron Energy passes another planning hurdle for its proposed 700 MW wind farm and 1800 MWh battery project in NSW. The post...

HuidaGene Therapeutics (HuidaGene), a global clinical─stage biotechnology company developing genome medicines, announced that the US FDA has cleared...